Clinical Trials Directory

Trials / Conditions / Fungemia

Fungemia

20 registered clinical trials studyying Fungemia — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingClinical Efectiveness of a Multiplex PCR-Based Rapid Diagnostic Method in Bloodstream Infections
NCT07408544
Istanbul Medipol University Hospital—
CompletedStudy of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in A
NCT04368559
Mundipharma Research LimitedPhase 3
CompletedClinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia
NCT03876990
University Hospital, GrenobleN/A
UnknownImpact of Rapid Pathogen Identification From Blood Cultures (RABbIT)
NCT02743585
Tan Tock Seng HospitalN/A
CompletedCD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidias
NCT02734862
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 2
CompletedClinical Performance of the Accelerate ID/AST System for Positive Blood Culture
NCT02719769
Accelerate Diagnostics, Inc.—
CompletedRapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
NCT01898208
Mayo ClinicN/A
CompletedProspective Population Study on Candidemia in Spain
NCT01236261
Fundacion SEIMC-GESIDA—
CompletedEvaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood C
NCT01450358
Instituto do CoracaoPhase 4
CompletedClinical Evaluation of Novel Biomarkers in Patients With Septicemia
NCT01359891
Medical University of Graz—
CompletedAnidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
NCT00841971
University of PittsburghPhase 4
TerminatedAn Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Se
NCT00806351
PfizerPhase 3
UnknownCaspofungin as Prophylaxis in High Risk Liver Transplantation Recipients
NCT01260974
Azienda Ospedaliera di PadovaPhase 2
TerminatedAn Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of De
NCT00805740
PfizerPhase 3
CompletedA Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections
NCT00794703
Astellas Pharma IncPhase 3
UnknownEvaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
NCT00460330
Peking University—
CompletedVoriconazole as Prophylaxis for Liver Transplant Recipients
NCT00177788
University of Pittsburgh—
CompletedSafety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections
NCT00027248
BioWest Therapeutics IncPhase 3
CompletedComparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone
NCT00001937
National Cancer Institute (NCI)Phase 3
CompletedAn Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voricon
NCT00001810
National Cancer Institute (NCI)Phase 3